-+ 0.00%
-+ 0.00%
-+ 0.00%

COMPASS THERAPEUTICS - MEDIAN DURATION OF RESPONSE 4.9 MONTHS; DISEASE CONTROL RATE 62.2% VS. 36.8%

Reuters·10/24/2026 08:17:12